Evidence map›Paper›PMID 36397054›Full record

Trial reportBMC musculoskeletal disorders2022

Structural tissue damage and 24-month progression of semi-quantitative MRI biomarkers of knee osteoarthritis in the IMI-APPROACH cohort.

Frank W Roemer, Mylène Jansen, Anne C A Marijnissen, Ali Guermazi, Rafael Heiss, Susanne Maschek, Agnes Lalande, Francisco J Blanco, Francis Berenbaum, Lotte A van de Stadt and 9 more

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMC musculoskeletal disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03883568 (A 2-year Multicentre, EU, Exploratory Study Without Therapeutic Benefit in Patients With Knee Osteoarthritis to Describe, Validate, and Predict Phenotypes of Knee Osteoarthritis by Use of Clinical, Imaging, and Biochemical), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03883568 completednot on this map

A 2-year Multicentre, EU, Exploratory Study Without Therapeutic Benefit in Patients With Knee Osteoarthritis to Describe, Validate, and Predict Phenotypes of Knee Osteoarthritis by Use of Clinical, Imaging, and Biochemical (Bio)Markers.

TypeobservationalSponsorF.P.J.G. LafeberRan2018 to 2021Enrolled297ConditionsKnee Osteoarthritis
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 8 countries.

Frank W RoemerDepartment of Radiology, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Maximiliansplatz 3, 91054, Erlangen, Germany. frank.roemer@uk-erlangen.de.
Mylène JansenUniversity Medical Center Utrecht, Utrecht, The Netherlands.
Anne C A MarijnissenUniversity Medical Center Utrecht, Utrecht, The Netherlands.
Ali GuermaziQuantitative Imaging Center, Department of Radiology, Boston University School of Medicine, Boston, MA, USA.
Rafael HeissDepartment of Radiology, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Maximiliansplatz 3, 91054, Erlangen, Germany.
Susanne MaschekChondrometrics GmbH, Freilassing, Germany.
Agnes LalandeInstitut de Recherches Internationales Servier, Suresnes, France.
Francisco J BlancoServicio de Reumatologia, INIBIC- Universidade de A Coruña, A Coruña, Spain.
Francis BerenbaumDepartment of Rheumatology, AP-HP Saint-Antoine Hospital, Paris, France.
Lotte A van de StadtDepartment of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Margreet KloppenburgDepartment of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Ida K HaugenDivision of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Christoph H LadelIndependent Consultant, Darmstadt, Germany.
Jaume BacarditSchool of Computing, Newcastle University, Newcastle, UK.
Anna WisserChondrometrics GmbH, Freilassing, Germany.
Felix EcksteinChondrometrics GmbH, Freilassing, Germany.
Floris P J G LafeberUniversity Medical Center Utrecht, Utrecht, The Netherlands.
Harrie H WeinansUniversity Medical Center Utrecht, Utrecht, The Netherlands.
Wolfgang WirthChondrometrics GmbH, Freilassing, Germany.
Paracelsus Medical University · ATUniversity Medical Center Utrecht · NLFriedrich-Alexander-Universität Erlangen-Nürnberg · DELeiden University Medical Center · NLAssistance Publique – Hôpitaux de Paris · FRDiakonhjemmet Hospital · NOFacility for Antiproton and Ion Research · DEImaging Center · USInstitut des Hautes Études Scientifiques · FRNewcastle University · GBUniversidade da Coruña · ES

Funding

The research leading to these results have received support from the Innovative Medicines Initiative Joint Undertaking under Grant Agreement no 115770, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. See www.imi.europa.eu and www.approachproject.eu. 115770
6 · The paper itself

Abstract

backgroundThe IMI-APPROACH cohort is an exploratory, 5-centre, 2-year prospective follow-up study of knee osteoarthritis (OA). Aim was to describe baseline multi-tissue semiquantitative MRI evaluation of index knees and to describe change for different MRI features based on number of subregion-approaches and change in maximum grades over a 24-month period.

methodsMRIs were acquired using 1.5 T or 3 T MRI systems and assessed using the semi-quantitative MRI OA Knee Scoring (MOAKS) system. MRIs were read at baseline and 24-months for cartilage damage, bone marrow lesions (BML), osteophytes, meniscal damage and extrusion, and Hoffa- and effusion-synovitis. In descriptive fashion, the frequencies of MRI features at baseline and change in these imaging biomarkers over time are presented for the entire sample in a subregional and maximum score approach for most features. Differences between knees without and with structural radiographic (R) OA are analyzed in addition.

resultsTwo hundred eighty-nine participants had readable baseline MRI examinations. Mean age was 66.6 ± 7.1 years and participants had a mean BMI of 28.1 ± 5.3 kg/m

conclusionsA wide range of MRI-detected structural pathologies was present in the IMI-APPROACH cohort. Baseline prevalence and change of features was substantially more common in the ROA subgroup compared to the knees without ROA.

trial registrationClinicaltrials.gov identification: NCT03883568.

Indexed as

Cartilage, ArticularCartilage DiseasesOsteoarthritis, KneeAgedBiomarkersFollow-Up StudiesHumansMagnetic Resonance ImagingMiddle AgedProspective StudiesBiomarkersKneeMRIOsteoarthritisProgression; reliability

Identifiers

PMID36397054
PMCPMC9670371
OpenAlexW4309170382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.